Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Wang Fangzheng, Jiang Chuner, Ye Zhimin, Sun Quanquan, Liu Tongxin, Xu Min, Wu Peng, Long Bin, Masoto Sakamoto, Wang Yuezhen, Yan Fengqin, Fu Zhenfu, Jiang Yangming
Published Oct 6, 2017 · Vol. 8, No. 55 · pp. 94117-94128
Michelle A. Schultz, Andrew M. Diaz, Sharon Smite, Anna R. Lay, Brian DeCant, Ronald McKinney, Windel E. Mascarinas, Yinglin Xia, Carola Neumann, David Bentrem, David W. Dawson, Paul J. Grippo
Published Oct 4, 2017 · Vol. 8, No. 54 · pp. 92667-92681
Theresa Benezeder, Verena Tiran, Alexandra A.N. Treitler, Christoph Suppan, Christopher Rossmann, Herbert Stoeger, Richard J. Cote, Ram H. Datar, Marija Balic, Nadia Dandachi
Published Sep 30, 2017 · Vol. 8, No. 54 · pp. 92483-92496
